Medication Delivery Solutions was Becton Dickinson’s largest revenue line in fiscal 2025, bringing in $4.58B of $21.84B (21%).
| Organizational Unit | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Integrated Diagnostic Solutions | $4.19B | — | — | — | ||||
| Medication Delivery Solutions | $4.31B | $4.29B | $4.43B | $4.58B | ||||
| Medication Management Solutions | $2.53B | $2.98B | $3.30B | $3.47B | ||||
| Pharmaceutical Systems | $2.00B | $2.23B | $2.27B | $2.32B | ||||
| Diagnostic Solutions | — | $1.89B | $1.85B | $1.84B | ||||
| Specimen Management | — | $1.74B | $1.83B | $1.87B | ||||
| Preanalytical Systems | — | — | — | — | ||||
| Peripheral Intervention | $1.76B | $1.87B | $1.93B | $2.00B | ||||
| Diagnostic Systems | — | — | — | — | ||||
| Biosciences | $1.38B | $1.51B | $1.51B | $1.46B | ||||
| Urology & Critical Care | $1.31B | $1.37B | $1.55B | $1.65B | ||||
| Surgery | $1.40B | $1.50B | $1.49B | $1.57B | ||||
| Diabetes Care | — | — | — | — | ||||
| Advanced Patient Monitoring | — | — | $74.00M | $1.08B | ||||
| Corporate & All Other | — | — | -$67.00M | — | ||||
| Total | $18.87B | $19.37B | $20.18B | $21.84B |
Becton Dickinson brought in $21.84B from its 10 revenue lines in fiscal 2025, the year ended September 30, 2025. Becton Dickinson regrouped these revenue lines after fiscal 2024, so the total does not compare directly with that year's $20.18B. Medication Delivery Solutions was the largest at $4.58B (20.9%), ahead of Medication Management Solutions at $3.47B (15.9%) and Pharmaceutical Systems at $2.32B (10.6%). The other seven revenue lines brought in $11.47B combined.
Compared with fiscal 2024, Advanced Patient Monitoring grew fastest, up 1,362.2% to $1.08B, while Biosciences fell the most, down 3.6% to $1.46B.
Becton Dickinson began breaking out Diagnostic Solutions in fiscal 2023, Specimen Management in fiscal 2023 and Advanced Patient Monitoring in fiscal 2024. Becton Dickinson stopped reporting Integrated Diagnostic Solutions as a separate revenue line after fiscal 2022, when it brought in $4.19B.
United States was Becton Dickinson’s largest region in fiscal 2025, bringing in $12.79B of $21.84B (59%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $10.72B | $11.11B | $11.66B | $12.79B | |||||||||||||
| Emea | $4.04B | $4.24B | $4.40B | $4.73B | |||||||||||||
| Emea (A) | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group One | — | — | — | — | |||||||||||||
| Europe | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group Two | — | — | — | — | |||||||||||||
| Greater Asia | $3.05B | $2.91B | $2.91B | $3.09B | |||||||||||||
| Other | $1.06B | $1.10B | $1.21B | $1.23B | |||||||||||||
| Other (A) | — | — | — | — | |||||||||||||
| Others | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group Four | — | — | — | — | |||||||||||||
| Asia Pacific | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group Three | — | — | — | — | |||||||||||||
| Total | $18.87B | $19.37B | $20.18B | $21.84B |
Becton Dickinson brought in $21.84B from its four regions in fiscal 2025, the year ended September 30, 2025. That was up 8.2% from $20.18B in fiscal 2024. United States was the largest at $12.79B (58.6%), ahead of Emea at $4.73B (21.7%) and Greater Asia at $3.09B (14.2%). The remaining region, Other, brought in $1.23B.
Compared with fiscal 2024, United States grew fastest, up 9.7% to $12.79B. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $18.87B to $21.84B, a compound annual growth rate of 5.0%. United States' share of the total rose from 56.8% to 58.6%.
Medical was Becton Dickinson’s largest segment in fiscal 2025, bringing in $11.46B of $21.84B (52%).
| Segment | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | $8.84B | $9.50B | $10.07B | $11.46B | |||||||||||
| Life Sciences | $5.56B | $5.13B | $5.19B | $5.17B | |||||||||||
| Interventional | $4.46B | $4.74B | $4.98B | $5.22B | |||||||||||
| Diagnostics | — | — | — | — | |||||||||||
| Biosciences | — | — | — | — | |||||||||||
| Corporate & All Other | — | — | -$67.00M | — | |||||||||||
| Total | $18.87B | $19.37B | $20.18B | $21.84B |
Becton Dickinson brought in $21.84B from its three segments in fiscal 2025, the year ended September 30, 2025. Becton Dickinson regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $20.18B. Medical was the largest at $11.46B (52.5%), ahead of Interventional at $5.22B (23.9%) and Life Sciences at $5.17B (23.7%).
Compared with fiscal 2024, Medical grew fastest, up 13.7% to $11.46B, while Life Sciences fell the most, down 0.5% to $5.17B. From fiscal 2022 to 2025, combined revenue from these segments grew from $18.87B to $21.84B, a compound annual growth rate of 5.0%. Medical's share of the total rose from 46.9% to 52.5%.
Becton Dickinson (BDX) reports its revenue by organizational unit, by geography and by segment. In fiscal 2025, Medication Delivery Solutions was its largest revenue line, bringing in $4.58B (20.9% of the total), followed by Medication Management Solutions at $3.47B (15.9%).
Medication Delivery Solutions was Becton Dickinson's largest revenue line in fiscal 2025, bringing in $4.58B, or 20.9% of the $21.84B total across its 10 revenue lines.
United States was Becton Dickinson's largest region in fiscal 2025, bringing in $12.79B, or 58.6% of the $21.84B total across its four regions.
Medical was Becton Dickinson's largest segment in fiscal 2025, bringing in $11.46B, or 52.5% of the $21.84B total across its three segments.
Among Becton Dickinson's regions that make up at least 2% of revenue, United States grew fastest in fiscal 2025, up 9.7% from $11.66B to $12.79B.
Every figure comes from Becton Dickinson's annual financial filings, as reported. Each line keeps the name Becton Dickinson gives it, and years follow its fiscal calendar.
Becton Dickinson's revenue by organizational unit goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.